Trial NCT02373241

View at ClinicalTrials.gov 
Org. Study IDs: F141107009
Secondary IDs: 1K23HL127100-01

Last trial update was posted on 2024-04-03

MeSH Interventions

Losartan

MeSH Conditions

Anemia, Sickle Cell Hypertension Kidney Diseases Proteinuria

Other Conditions

Kidney Disease Sickle Cell Disease

Stopping Reasons

Estimated GFR was determined not to be a reliable endpoint for this study. We identified significant variabilty in annual eGFR that it became inappropriate to randomize to a medication but use EGFR as the primary endpoint.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID